Search

Search Constraints

You searched for: Author/Creator Nathan, Steven D.

Search Results

2. Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) – A subgroup analysis of the ARIES-E clinical trial. (August 2016)

5. Cardiorespiratory Function Before and After Aerobic Exercise Training in Patients With Interstitial Lung Disease. Issue 1 (January 2015)

6. Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease. Issue 4 (April 2015)

7. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. (June 2018)

8. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension. (22nd August 2022)

9. CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Issue 7 (10th June 2022)

10. Comparison of donor‐derived cell‐free DNA between single versus double lung transplant recipients. Issue 10 (12th April 2022)